Correction to: Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study

Saved in:

Bibliographic Details
Published in:	Adv Ther
Main Authors:	Perumal, Jai, Balabanov, Roumen, Su, Ray, Chang, Roger, Balcer, Laura, Galetta, Steven, Campagnolo, Denise I., Avila, Robin, Lee, Lily, Rutledge, Danette, Fox, Robert J.
Format:	Artigo
Language:	Inglês
Published:	Springer Healthcare 2021
Subjects:	Correction
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC8280011/ https://ncbi.nlm.nih.gov/pubmed/34159559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-021-01815-6
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items